Sentence and cancer type
Showing 281-300 of 577 items.
SentenceCancertype
27-bp deletion in the ret proto-oncogene as a somatic mutation associated with medullary thyroid carcinoma. thyroid,
Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas. thyroid,
Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. thyroid,
Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma. thyroid,
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. thyroid,
Alterations of RET oncogene in human adrenal tumors. kidney,
Multiple endocrine neoplasia type 2-associated RET proto-oncogene mutations do not contribute to the pathogenesis of sporadic parathyroid tumors. thyroid,
[A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions]. thyroid,
Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. thyroid,
The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. thyroid,
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. thyroid,
RET proto-oncogene: role in kidney development and molecular pathology. kidney,
Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. None
FISH mapping of the mouse Ret oncogene to the junction of G-bands E3/F1 on chromosome 6 indicates a need for reassessment of the physical and consensus maps. None
RET proto-oncogene in the development of human cancer. None
Point nucleotidic changes in both the RET proto-oncogene and the endothelin-B receptor gene in a Hirschsprung disease patient associated with Down syndrome. None
Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. None
Mutational analysis of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung s disease. None
De novo RET proto-oncogene mutation in a patient with multiple endocrine neoplasia type 2B. None
Expression of RET proto-oncogene and GDNF deficit in Hirschsprung s disease. None